Expression of efflux pump mexab-oprm and oprd of pseudomonas aeruginosa strains isolated from clinical samples using qrt-pcr

Archives of Iranian Medicine

Volumn 18, Issue 2, 2014, Pages 102-108

  Arabestani, Mohammad Reza ^a,b   Rajabpour, Mojtaba ^a   Mashouf, Rasoul Yousefi ^a   Alikhani, Mohammad Yousef ^a,b   Mousavi, Seyed Masoud ^a  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibiotic; Gene expression; MIC; Pseudomonas aeruginosa; QRT PCR

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CARBAPENEM; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEXA PROTEIN; MEXB PROTEIN; OPRD PROTEIN; OPRM PROTEIN; OXIDOREDUCTASE; PROTEIN; PYOCYANINE; QUINOLONE; TOBRAMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CARRIER PROTEIN; MEXA PROTEIN, PSEUDOMONAS AERUGINOSA; MEXB PROTEIN, PSEUDOMONAS AERUGINOSA; OPRD PROTEIN, PSEUDOMONAS AERUGINOSA; OPRM PROTEIN, PSEUDOMONAS AERUGINOSA; OUTER MEMBRANE PROTEIN; PORIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; DISK DIFFUSION; DNA EXTRACTION; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; GRAM STAINING; HOSPITAL PATIENT; HUMAN; MEXAB OPRM; MINIMUM INHIBITORY CONCENTRATION; OPRD; PHENOTYPE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; CROSS INFECTION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; REAL TIME POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; PORINS; PSEUDOMONAS AERUGINOSA; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84922069478     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Jaffe Rl, Lane JD, Bates CW. Real-time identification of Pseudomonas aeruginosa direct from clinical samples using a rapid extraction method and polymerase chain reaction (PCR). J Clin Lab Anal. 2001; 15(3): 131-137.
2. Vanhems P, Lepape A, Savey A, Jambou P, Fabry J. Nosocomial pulmonary infection by antimicrobial resistant bacteria of patients hospitalized in intensive care units risk factors and survival. J Hosp Infect. 2000; 45(2): 98-106.
3. Poole K. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother. 2000; 44: 2233-2241.
4. Lomovskaya O, Warren MS, Lee A, Galazzo J, Fronko R, Lee M, et al. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother. 2001; 45(1): 105-116.
5. Saier MH Jr, Paulsen I. Phylogeny of multidrug transporters. Semin CellDevBiol. 2001; 12(3): 205-213.
6. Poole K, Tetro K, Zhao Q, Neshat S, Heinrichs DE, Bianco N. Expression of the multidrug resistance operon MexA-mexB-oprM in Pseudomonas aeruginosa mexR encodes aregulator of operon expression. Antimicrob Agents Chemother. 1996; 40: 2021-2028.
7. Saito K, Yoneyama H, Nakae T. nalB-type mutations causing the over-expression of the MexAB-OprM efflux pump are located in the mexR gene of the Pseudomonas aeruginosa chromosome. FEMS Microbiol Lett. 1999; 179(1): 67-72.
8. Quinn JP, Dudek EJ, DiVincenzo CA, Lucks DA, Lerner SA. Emergence of resistance to imipenem during therapy for Pseudomonas ae-ruginosa infections. J Infect Dis. 1986; 154: 289-294.
9. Quale J, Bratu S, Gupta J, Landman D. Interplay of efflux system. ampC and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother. 2006; 50(5): 1633-1641.
10. Spilker T, Coeney T, Vandamme P, LiPuma JJ. PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J Clin Microbiol. 2004; 42(5): 2074-2079.
11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing Twenty-Third Informational Supplement. M100- S23. Pennsylvania: Clinical and Laboratory Standards institute; 2013.
12. Dumas JLJ, van Delden C, Perron K, Köhler T. Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR. FEMS Microbiol Lett Jan. 2006; 254(2): 217-225.
13. Joklik WK, Willett HP, Amos DB, Zinsser H. Zinsser Microbiology. 20th ed. Norwalk. CT: Appleton & Lange, 1992.
14. Rajat Rakesh M, Ninama Govind L, Mistry K, Parmar R Patel K, Vegad MM. Antibiotic resistance pattern in Pseudomonas aeruginosa species isolated at a tertiary care hospital, Ahmadabad. Natl J Med Res. 2012; 2(2): 156-159.
15. Fazeli H, Moghim S, Narimani T, Arabestani MR, Ghoddousi AR. Pseudomonas aeruginosa infections in patients, hospital means, and personnel's specimens. J Res Med Sci. 2012; 17(4): 332-337.
16. Anil C, Shahid RM. Antimicrobial Suseptibility Patterns of Pseudomonas aeroginosa clinical isolates at tertiary care hospital in Kath-mando, Nepal. Asian JPharm Clin Res. 2013; 6(3): 235-238.
17. Nikokar I, Tishayar A, Flakiyan Z, Alijani K, Rehana-banisaeed S, Hossinpour M, et al. Antibiotic resistance and frequency of class 1 in-tegrons among Pseudomonas aeruginosa, isolated from burn patients in Gilan, Iran. Iran J Microbiol. 2013; 5(1): 36-41.
18. Kianpour F, Havaei SA, Hosseini MM. Evaluation of Pseudomonas aeroginosa isolated from cutaneous infections and determination of drug resistance pattern in patients of Alzahra Hospital in Esfahan. J Isfahan Med Sch. 2010; 28(110): 1-6.
19. Shahcheraghi F, Feizabadi MM, Yamin V, Abiri R, Abedian Z. Se-rovar determination, drug resistance pattern of Pseudomonas aeru-ginosa from burn patient's at two hospitals of Tehran. Burns. 2003; 29(6): 547-551.
20. Chaudhari V, Sandeep G, Mehta M. Antibiotic resistance patterns of Pseudomonas aeruginosa in a tertiary care hospital in Central India. Int JMed Sci Public Health. 2013; 2(2): 386-389.
21. Niitsuma K, Saitoh M, Kojimabara M, Kashiwabara N, Aoki T, To-mizawa M, et al. Antimicrobial susceptibility of Pseudomonas aeru-ginosa isolated in Fukushima prefecture. Jpn JAntibiot. 2001; 54(2): 79-87.
22. Rio Y, Pina P, Jurin F, Allouch P, Didion J, Chardon H, et al. Susceptibility of Pseudomonas aeruginosa to antibiotics isolated from patients of intensive care units in France in 1998. Resistant phenotypes to beta-lactams. Pathol Biol (Paris). 2002; 50(1): 12-17.
23. Imani Foolad AA, Rostami Z, Shapouri R. Antimicrobial resistance and ESBL prevalence in Pseudomonas aeruginosa strains isolated from clinical specimen by phenotypic and genotypic Methods. J Arde-bil Med Sci Univ. 2011; 10(3): 189-198.
24. Bouza E, Garcia-Garrot F, Cercenado E, Marin M, Diaz MS. Pseudomonas aeruginosa a survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa Study Group. Antimicrob Agents Chemother. 1999; 43(4): 981-982.
25. Shawar RM, Macleod DL, Garber RL, Burns JL, Stapp JR, Clausen CR, et al. Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother. 1999; 43(12): 2877-2880.
26. Cavallo JD, Fabri R Leblanc F, Nicolas-Chanoine MH, Thabaut A. Antibiotic susceptibility and mechanisms of beta-lactam resistance in 1310 strains of Pseudomonas aeruginosa: a French multicentre study (1996). J Antimicrob Chemother. 2000; 46(1): 133-136.
27. Kato K, Iwai S, Kumasaka K, Horikoshi A, Inada S, Inamatsu T, et al. Survey of antibiotic resistance in Pseudomonas aeruginosa by The Tokyo Johoku Association of Pseudomonas Studies. J Infect Chemother. 2001; 7(4): 258-262.
28. Ibtesam Ghadban AA, Amera Khadier AA, Noor Hashim K, Sabah AB. Occurrence of MexAB-OprM efflux pump Operon on septicemic Pseudomonas aeruginosa chromosome. The Iraqi Postgraduate Med J. 2012; 11(1): 97-102.
29. Sacha P, Wieczorek P, Ojdana D, Hauschild T, Milewski R Czaban S, et al. Expression of MexAB-OprM efflux pump system and susceptibility to antibiotics of different Pseudomonas aeruginosa clones isolated from patients hospitalized in two intensive care units at University Hospital in Bialystok (northeastern Poland) between January 2002 and December 2009. APMIS. 2014; 122(10): 931-940.
30. Aghazadeh M, Hojabri Z, Mahdian R Nahaei MR, Rahmati M, Ho-jabri T, et al. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-b-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients. Infect Genet Evol. 2014; 24: 187-192.
31. Yoneyama H OA, Tsuda M, Nakae T. The role of mex-gene products in antibiotic extrusion in Pseudomonas aeruginosa. Biochem Biophys Res Commun. 1997; 233(3): 611-618.
32. Ozer B, Duran N, Onlen Y, Savas L. Efflux pump genes and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from lower respiratory tract infections acquired in an intensive care unit. J Antibiot (Tokyo). 2012; 65(1): 9-13.